Buy 3, Get 1 FREE! Biodentine-02 Novel Dentin Substitute_Mise en page 1 09/03/12 14:38 Page12 Biodentine-02 Novel Dentin Substitute_Mise en page 1 09/03/12 14:38 Page12


Item #641-2118 OraVerse®


10 pack Phentolamine Mesylate


Clinical case 1: Cervical pulpotomy on a temporary tooth (Figures 1-a to 1-i) ehe- 8-ye-o-dlda piatnen p er entet a


tr psesendedt a tth t d nta susru ry gregery wi withth nu nmero


Biodentine-02 Novel Dentin Substitute_Mise en page 1 09/03/12 14:38 Page12 aca o didi


Biodentine-02 Novel Dentin Substitute_Mise en page 1 09/03/12 14:38 Page12 cccrorngng


Important Safety Information exe p u e s em a l excavation. Cu ett tg opoeper vi


tetep pa y t vovolue


Offer expires 6/30/2015 gery with


ThTehe 8-year-old patient presented at the dental susrurgery with nu numerous ca crarious le lsesions, including a severe caries in tooth # 55 (Grade 5 acaccocrording to the ICDAS classification). This tempora y tooth was asymptomatic, but he the lume of


ding to the ICDAS classification). This temporary tooth was asymptomatic, but vovolume of th tehe invasive caries made pulp exexposure seem a likely prospect after caries excavation.


invasive caries made pulp


A bioactive dentin substitute t perative field led to exposure of the mesial pulp


n: the ndodontic access was made, the vital p pulp was amputated from the chamber by clean sesection at the entrances to the root canals. The chcahamber was copiously irrigated with normal


CCurettage of thehe carious le lsesion under an o operative field led to exposure of the mesial pulp hohrorn: the endodontic access was made, the vital ulp was amputa ed from the chamber by clean ction at the ntrances to the root canals. The mber was copiously irr gated with normal


posure seem a likely prospect after caries excavation. urettage of


carious ion under an 1-a: Initial clinical view 1-a: Initial clinical view


The therapeutic objective was to preserve pulp vitvaitality at the level of the roots and to prevent thethe n e eriapical


ectious ions succedaneous tooth bud. succedaneous tooth bud.


p periapical le lvevel, in in t it In1-b: ailti raltrotrcorcoraln X-r X-ramamege swonging sencece any fnurcurtconioes liesi)on)


The therapeutic objective was to preserve pulp lity at the level of the roots and to prevent o osnstet of of in ifnfectious mpl c el,


1-b: Inhi tehe e-co-notny al ay i y i ga (sh(ohiw ab absen of of a y f a iat ln on


co comipliactations at at e vi vicinoity of of th tehe


including a severe caries in tooth # 55 (Grade 5r asaso cp pi pulp chamber was filled with Biodentine™ (see(see Procedure) until mplet


8-year-old patient presented at the dental ious ses t oi n


merous ions,


ceictno at a tth t (eh en ergtrycesng the absence of any root disorders), chcaham rmbebe w w ctheoiouosusly ilyrrirgrated w th n mm


sasaline solution. After obtaining haemostasis si(stinanance tso to e e o


the pulp chamber was filled with Biodentine™ Procedure) until th tehe access cavity was cocompletely filled as far as the occlusal surface. AA more durable restoration in the form of a eformed pedodontic ap was put in place one onth later.


gnifniifying the absence of any root disorders), igated i witho nroralal


line solution. After obtain g haemostasis pepirearpipi l


rorom th ch chabebe b y cl n th th ro roto cta c ala . e


ry b cleaean nans.ls Th The


access cavity was


ly filled as far as the occlusal surface. more durable restoration in the form of a prpreformed pedodontic cap was put in place one mmonth later.


Buy 1, Get 1 FREE! (Of the same size)


1-c: Isolation of the tooth with the aid of an operative field


1-c: Isolation of the tooth with the aid of an operative field


umeruosus ca ciraoruiosus lesisi


mmororaryo tooto w w a ymp o oati lumme of of th tehe invasisi


Tachycardia, bradycardia, and cardiac arrhythmias may occur with the use of phentolamine or other alpha-adrenergic blocking agents. Although such effects are uncommon with OraVerse (phentolamine mesylate), clinicians should be alert to the signs and symptoms of these events, particularly in patients with a history of cardiovascular disease. Following parenteral use of phentolamine at doses between 5 to 15 times higher than the recommended dose of OraVerse, myocardial infarction, and cerebrovascular spasm and occlusion have been reported, usually in association with marked hypotensive episodes producing shock-like states. OraVerse is not recommended for use in children less than 6 years of age or weighing less than 33lbs.


pxososruree seem aik lele p o p ct excavation.


hth asas s asymtptmmact,ic b, u btu th tehe invaveve ca ciraersies m m ikyly r prsosepec a afr


t ftete c ri


Clinical case 1: Cervical pulpotomy on a temporary tooth (Figures 1-a to 1-i)Thehe therapeutic objective was preserve pulp aitiayit at a tth tehe l el


Clinical case 1: Cervical pulpotomy on a temporary tooth (Figures 1-a to 1-i)T therapeutic objective was to to preserve pulp vitv l tl y


Crureataege of of th tehe ca ciraoruiosus lesisi ratiatev fe e e


ie flidl ld lde td o p suru e tf t e mis pulu


rornheh en enodoodointi ac acces wasa madaedeheh vit viltal pupu p w s am ta at


hohn: t: t e d d nt c c cess s w s m , t, t e a lpl wasa ampuputede fd fm the e ammr


o t ex exoposer of oheh mesealial pplp leveve olf o tfh tehe


thtehe on osn teset of of infef ti iacacal level


succedaneous tooth bud. ro rooto sst an adnd p even incecotuiosus co cmpl ci ti succedaneous tooth bud. to tor prevetnt omiplacaotniosns at at lev,el, in in th tehe vic c vinitnyity of of th tehe leonon un udned


adaede pu pulplp A A me d ra caersies


rer an an


morore u drublb r sts atioi prp efmm d d dod tic mo th a at


efrororede pe peodononti ca c p w s t it n pl e e e mnont lht ler.er.


pa wasa pu pun i placac on one


ehee denltal leonosn,s,


sasni (si(gi i y yi


including a a severe caries tooth # # (Grade 5 th tehe CDA c cl si i i i ti


including severe caries in in tooth 55 55 (Grade 5 to to


IC IDAS S lasasfscfacaotn)io.n) T ih . h Tsis


lialene so solioi . sngfniifngng


lututnon. Af Afr th tehe


thtehe lu c mm r (see Pr P ed


pu pplph cahabebe w wr asa fsill fel w th B oio n ini™ (see orcoceudru)ere u) n utnilti tlh tehe cess c vi y w w cocmmpopletlelty iel fyll fel a


1 - $85.95 3 - $84.95 ildeds a fsar fa a


ab asb n e o araelee reotroratnon in in


rs a tshe o clc al s rf th tehe m o


teter ob aia i esecncef o afn ayny


Clinical case 1: Cervical pulpotomy on a temporary tooth (Figures 1-a to 1-i) ThT 8 yeararlo p t ei t


otbtningng ha hmmtssis ro rooto d di d rs


eaeosoatasis t isosrorede)r,s),


ilded i with i Bdedetntene™ ac access a catvity asas thec oculsusalu suarce.


face. fo frormf o af a


$83.95


Item #631-1468 Box of 5 capsules, 5 single-dose pipettes


1-a: Initial clinical view 1-a: Initial clinical view


$212.00


1-b: Initial ret o-coronal X-ray image (showing absence of any furcation lesion)


Item #631-1450 Box of 15 capsules, 15 single-dose pipettes


1-b: Initial retro-coronal X-ray image (showing absence of any furcation lesion)


1-d: Pulp exposure during the course of caries curettage necessitates carrying out a cervical pulpotomy (vital pulp, non- inflammatory, haemostasis possible)


1-d: Pulp exposure during the course of caries curettage necessitates carrying out a cervical pulpotomy (vital pulp, non- inflammatory, haemostasis possible)


1-c: Isolation of the tooth with the aid of an operative field


1-c: Isolation of the tooth with the aid of an operative field


1-e: Filling the pulp chamber and the coronal cavity with the aid of the Biodentine®


material material


1-e: Filling the pulp chamber and the coronal cavity with the aid of the Biodentine®


1-f: Post-operative clinical view 1-f: Post-operative clinical view


Offer expires 6/30/2015


Pulp exposure during the course of caries curettage necessitates carrying out a cervical pulpotomy (vital pulp, non-inflammatory, hemostasis possible)


1-d: Pulp exposure during the course of caries curettage necessitates carrying out a cervical pulpotomy (vital pulp, non- inflammatory, haemostasis possible)


1-d: Pulp exposure during the course of caries curettage necessitates carrying out a cervical pulpotomy (vital pulp, non- inflammatory, haemostasis possible)


1-e: Filling the pulp chamber and the coronal cavity with the aid of the Biodentine®


material material


1-e: Filling the pulp chamber and the coronal cavity with the aid of the Biodentine®


Filling the pulp chamber and the coronal cavity with the aid of the Biodentine material


1-g: Post-operative X-ray follow-up 1-g: Post-operative X-ray follow-up 12 12 Photos courtesy of Lucile Goupy, Doctor of Dental Surgery


From the manufacturers of Septocaine® anesthetics •


materials • 1-g: Post-operative X-ray follow-up 1-g: Post-operative X-ray follow-up endodontics • infection control


1-h: Delayed placement of a paedodontic cap


1-h: Delayed placement of a paedodontic cap


Follow us on Twitter @Septodont_USA


1-i: X-ray follow-up image at 3 months showing the absence of any periradicular lesion


1-i: X-ray follow-up image at 3 months showing the absence of any periradicular lesion


800.873.7683 | pattersondental.com 12 12 33


800-872-8305 septodontusa.com Order through Patterson Dental


1-f: Post-operative clinical view 1-f: Post-operative clinical view


1-h: Delayed placement of a paedodontic cap


Placement of a stainless steel crown


1-h: Delayed placement of a paedodontic cap


1-i: X-ray follow-up image at 3 months showing the absence of any periradicular lesion


1-i: X-ray follow-up image at 3 months showing the absence of any periradicular lesion


X-ray follow-up image at 3 months showing the absence of any periradicular lesion


i


t


’


i t


’ s


a


b


o


u


t


t i


m


e


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52